Prospeo
Hero Section BackgroundHero Section Background
PharmaBlock Group

PharmaBlock Group Revenue

Pharmaceutical ManufacturingFlag of CN81 Huasheng Road, Jiangbei New Area, China201-500 Employees

$

PharmaBlock Group revenue & valuation

Annual revenue$68,800,000
Revenue per employee$292,000
Estimated valuation?$220,100,000
Total fundingNo funding

Key Contacts at PharmaBlock Group

Flag of DE

Axel Schlueter

Business Development Director Cdmo Europe

Flag of US

Celine Chen

Senior Director Of Business And Marketing Strategy

Flag of FR

Aixiao Aixiao

Director Of Business Development

Flag of CN

Larry Yuanxian Wang

Director Of R&D

Flag of CN

Jiezheng Hui

Engineering Director

Flag of US

Jason Qian

Principal Scientist, Director Of Analytical R&D

Flag of US

Zhenwei Lu

Director Of Structural Biology And Screening

Flag of CN

Lin Wang (王琳)

Associate Director Of Bbr

Flag of CN

Wayne Zheng

Sales & Bd Director

Flag of US

Guihui Chen

Scientific Director

Company overview

Headquarters81 Huasheng Road, Jiangbei New Area, Nanjing, Jiangsu 210032, CN
Phone number+864000255188
Website
NAICS3254
SIC283
Keywords
CMC, GMP, Catalysis, Cdmo, Process R&D, Custom Synthesis, Virtual Screening, Building Blocks, Fte Services, Manufacturing Of Key Intermediates And Apis, DEL, Flow Chemistry, Fbdd, Micropacked Bed
Founded2006
Employees201-500
Socials

PharmaBlock Group Email Formats

PharmaBlock Group uses 3 email formats. The most common is {first initial}_{last name} (e.g., j_doe@pharmablock.com), used 57.1% of the time.

FormatExamplePercentage
{first initial}_{last name}
j_doe@pharmablock.com
57.1%
{first name}_{last name}
john_doe@pharmablock.com
33.3%
{last name}_{first initial}
doe_j@pharmablock.com
9.5%

About PharmaBlock Group

PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) is a leading provider of innovative chemistry products & services throughout the pharmaceutical R&D process and commercial production. Its core businesses include: a rationally designed building blocks (BBs) collection, supplying from discovery, to development & commercial; development & manufacturing of RSMs, intermediates & APIs for drug development & commercial. Officially operated in 2008, PharmaBlock has rapidly gained recognition for its outstanding capabilities in the design, synthesis, & supply of novel BBs. It has generated a large and unique collection of high-quality and diverse BBs, which are increasingly adopted by drug hunters to enrich the structure options, improve compound quality, expand patent space and eventually accelerate drug discovery projects. Inspired by the BBs, it has established a powerful drug discovery platform for medicinal chemists to quickly identify hit/lead. The platform includes a set of efficient tools, including but not limited to FBDD, DELT, & Virtual Screening. Following the new molecules advancing from discovery to development, and into the market, the company is committed to a more comprehensive & long-term service to valued customers. In addition to strengthening process R&D capabilities & mfg. capacity to secure the sustainable supply of BBs, the company is providing CDMO solutions of RSMs, key intermediates & APIs. To further realize safe, efficient and green process & mfg., it has developed an advanced chemistry & engineering technology platform, featuring flow chemistry, micropacked bed hydrogenation, catalysis, crystallization, solid state chemistry etc. Over the past years, PharmaBlock has partnered with almost all the top pharmaceutical companies, and hundreds of small to medium-sized biotechs around the world. Our ever changing mission is to support clients to accelerate drug discovery & development, and move the new molecule to commercial in full speed.

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Entry
Director
Manager

Employees by Department

PharmaBlock Group has 46 employees across 13 departments.

Departments

Number of employees

Funding Data

Explore PharmaBlock Group's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2021-01-0114N/A

Funding Insights

1

Number of funding rounds

PharmaBlock Group Tech Stack

Discover the technologies and tools that power PharmaBlock Group's digital infrastructure, from frameworks to analytics platforms.

Ant Design

Ant Design

UI frameworks

Vue.js

Vue.js

JavaScript frameworks

Google Tag Manager

Google Tag Manager

Tag managers

Node.js

Node.js

Programming languages

Nginx

Nginx

Reverse proxies

Nuxt.js

Nuxt.js

JavaScript frameworks

Open Graph

Open Graph

Miscellaneous

core-js

core-js

JavaScript libraries

PWA

PWA

Miscellaneous

OpenResty

OpenResty

Web servers

Google Analytics

Google Analytics

Analytics

Webpack

Webpack

Miscellaneous

Frequently asked questions

PharmaBlock Group is located in 81 Huasheng Road, Jiangbei New Area, CN.
You can reach PharmaBlock Group at +864000255188.
PharmaBlock Group generates an estimated annual revenue of $68,760,000. This revenue figure reflects the company's market position and business performance in its industry.
PharmaBlock Group has an estimated valuation of $220,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
PharmaBlock Group was founded in 2006, making it 20 years old. The company has established itself as a significant player in its industry over this time.
PharmaBlock Group has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles